Page 127 - book

Type Name Of Product Dosage Form Strength Indication Status

In process of Registration
IRANIAN PHARMACEUTICAL COMPANIES DIRECTORY
Progesterone Ampoule 25 mg/1 ml in Iraq
Amenorrhea, Uterine
bleeding
Progesterone Ampoule 50 mg/1 ml

Sex Hor-
mones / Progesterone Suppository 200 mg Pre-menstrual syndrome,
Synthetics / Post-natal depression, Registered in Uzbekistan,
Semi-synthet- Amenorrhea, Fertility Georgia
ics
Progesterone Suppository 400 mg treatment

Hormone therapy, trans-
gender, female-to-male In process of Registration
Testosterone Enan- Ampoule 250 mg/1 ml (off-label use), Hypogo- in Iraq-
thate
nadism, male (primary or Registered in Afghanistan
hypogonadotropic)
Allergic states, Rheumatic
Betamethasone Ampoule 4 mg/1 ml disorders, Dermatolog- Registered in Afghanistan
ic diseases, Endocrine
disorders, Gastrointesti-
nal diseases, Neoplastic
diseases, Nervous system Registered in Iraq
Betamethasone Tablet 0.5 mg disorders, Ophthalmic
diseases, Renal diseases, - Afghanistan
Respiratory diseases,
Rheumatic disorders

Betamethasone Topical Ointment 0/10%
Dermatoses

Betamethasone Topical Cream 0/10%

Corticoste- Dexamethasone Tablet 0.5 mg
roids
Arthritis, Severe allergies,
asthma, Cancer
Dexamethasone Ampoule 8 mg/2 ml Registered in Iraq- Lebanon
Phosphate
Allergic states, Dermato-
logic diseases, Edematous
states, Endocrine disor-
ders, GI diseases, Hemato-
Hydrocortisone Tablet 10 mg
logic disorders, Neoplastic
diseases, Nervous system,
Ophthalmic diseases,
Respiratory diseases
Anal and genital pruritus
(external), atopic dermati-
Hydrocortisone Topical Ointment 1% tis, contact dermatitis, vul- Registered in Afghanistan
Acetate
var dermatitis, psoriasis,
seborrheic dermatitis

126